secwatch / observer
8-K filed May 19, 2026, 3:02 PM ET ticker CRD-A CIK 0000025475
other material confidence high sentiment neutral materiality 0.15

Crawford & Company shareholders elect directors, approve plan amendment, ratify KPMG at 2026 annual meeting

CRAWFORD & CO

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CRAWFORD & CO shareholders approved Proposal to approve an amendment to the Crawford & Company 2016 Omnibus Stock and Incentive Plan to fix the Plan termination date as May 13, 2032 at the 2026-05-14 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2026-05-14
Exact text from the filing
The shareholders approved the proposed amendment to the Plan and the termination date is fixed as May 13, 2032.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CRAWFORD & CO shareholders approved Ratification of Independent Registered Public Accountants at the 2026-05-14 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-05-14
Exact text from the filing
The shareholders ratified the appointment of KPMG, LLP as the independent registered public accounting firm for the Company for the 2026 fiscal year.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CRAWFORD & CO shareholders approved Election of Directors at the 2026-05-14 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-05-14
Exact text from the filing
All of the nominees for director listed below were elected to serve as directors until the Company’s next annual meeting of shareholders and until their successors are elected and qualified.
View on SEC.gov

546 shareholder votes filed in the last 30 days. Browse all shareholder votes →

CRAWFORD & CO filing history →

Source: SEC EDGAR
accession 0001104659-26-063769
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.